These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 29594582)

  • 61. Design and Investigation of Core/Shell GQDs/hMSN Nanoparticles as an Enhanced Drug Delivery Platform in Triple-Negative Breast Cancer.
    Yang D; Yao X; Dong J; Wang N; Du Y; Sun S; Gao L; Zhong Y; Qian C; Hong H
    Bioconjug Chem; 2018 Aug; 29(8):2776-2785. PubMed ID: 30011184
    [TBL] [Abstract][Full Text] [Related]  

  • 62. TPGS functionalized mesoporous silica nanoparticles for anticancer drug delivery to overcome multidrug resistance.
    Zhao P; Li L; Zhou S; Qiu L; Qian Z; Liu X; Cao X; Zhang H
    Mater Sci Eng C Mater Biol Appl; 2018 Mar; 84():108-117. PubMed ID: 29519418
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Demonstration of the lack of cytotoxicity of unmodified and folic acid modified graphene oxide quantum dots, and their application to fluorescence lifetime imaging of HaCaT cells.
    Goreham RV; Schroeder KL; Holmes A; Bradley SJ; Nann T
    Mikrochim Acta; 2018 Jan; 185(2):128. PubMed ID: 29594671
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Natural gelatin capped mesoporous silica nanoparticles for intracellular acid-triggered drug delivery.
    Zou Z; He D; He X; Wang K; Yang X; Qing Z; Zhou Q
    Langmuir; 2013 Oct; 29(41):12804-10. PubMed ID: 24073830
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Enzyme-induced and tumor-targeted drug delivery system based on multifunctional mesoporous silica nanoparticles.
    Cheng YJ; Luo GF; Zhu JY; Xu XD; Zeng X; Cheng DB; Li YM; Wu Y; Zhang XZ; Zhuo RX; He F
    ACS Appl Mater Interfaces; 2015 May; 7(17):9078-87. PubMed ID: 25893819
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts.
    Zhong Y; Zhang J; Cheng R; Deng C; Meng F; Xie F; Zhong Z
    J Control Release; 2015 May; 205():144-54. PubMed ID: 25596560
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Responsive delivery of drug cocktail via mesoporous silica nanolamps.
    Muhammad F; Guo M; Wang A; Zhao J; Qi W; Guo Y; Zhu G
    J Colloid Interface Sci; 2014 Nov; 434():1-8. PubMed ID: 25151090
    [TBL] [Abstract][Full Text] [Related]  

  • 68. GQDs-MSNs nanocomposite nanoparticles for simultaneous intracellular drug delivery and fluorescent imaging.
    Flak D; Przysiecka Ł; Nowaczyk G; Scheibe B; Kościński M; Jesionowski T; Jurga S
    J Nanopart Res; 2018; 20(11):306. PubMed ID: 30524192
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A Facile Way for Fabricating PEGylated Hollow Mesoporous Silica Nanoparticles and Their Drug Delivery Application.
    Teng X; Cheng S; Meng R; Zheng S; Yang L; Ma Q; Jiang W; He J
    J Nanosci Nanotechnol; 2015 May; 15(5):3773-9. PubMed ID: 26505004
    [TBL] [Abstract][Full Text] [Related]  

  • 70. pH and Ultrasound Dual-Responsive Polydopamine-Coated Mesoporous Silica Nanoparticles for Controlled Drug Delivery.
    Li X; Xie C; Xia H; Wang Z
    Langmuir; 2018 Aug; 34(34):9974-9981. PubMed ID: 30056720
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Quercetin and doxorubicin co-delivery using mesoporous silica nanoparticles enhance the efficacy of gastric carcinoma chemotherapy.
    Fang J; Zhang S; Xue X; Zhu X; Song S; Wang B; Jiang L; Qin M; Liang H; Gao L
    Int J Nanomedicine; 2018; 13():5113-5126. PubMed ID: 30233175
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Nitrogen-Doped Graphene Quantum Dots@SiO2 Nanoparticles as Electrochemiluminescence and Fluorescence Signal Indicators for Magnetically Controlled Aptasensor with Dual Detection Channels.
    Wang C; Qian J; Wang K; Hua M; Liu Q; Hao N; You T; Huang X
    ACS Appl Mater Interfaces; 2015 Dec; 7(48):26865-73. PubMed ID: 26524349
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Intracellular pH-Triggered, Targeted Drug Delivery to Cancer Cells by Multifunctional Envelope-Type Mesoporous Silica Nanocontainers.
    Yang K; Luo H; Zeng M; Jiang Y; Li J; Fu X
    ACS Appl Mater Interfaces; 2015 Aug; 7(31):17399-407. PubMed ID: 26196506
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Hyaluronic acid-decorated graphene oxide nanohybrids as nanocarriers for targeted and pH-responsive anticancer drug delivery.
    Song E; Han W; Li C; Cheng D; Li L; Liu L; Zhu G; Song Y; Tan W
    ACS Appl Mater Interfaces; 2014 Aug; 6(15):11882-90. PubMed ID: 25000539
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Temperature-sensitive copolymer-coated fluorescent mesoporous silica nanoparticles as a reactive oxygen species activated drug delivery system.
    Yu F; Wu H; Tang Y; Xu Y; Qian X; Zhu W
    Int J Pharm; 2018 Jan; 536(1):11-20. PubMed ID: 29146540
    [TBL] [Abstract][Full Text] [Related]  

  • 76. pH-Sensitive drug delivery system based on modified dextrin coated mesoporous silica nanoparticles.
    Chen H; Zheng D; Liu J; Kuang Y; Li Q; Zhang M; Ye H; Qin H; Xu Y; Li C; Jiang B
    Int J Biol Macromol; 2016 Apr; 85():596-603. PubMed ID: 26776872
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Biodegradable hybrid mesoporous silica nanoparticles for gene/chemo-synergetic therapy of breast cancer.
    Zhang B; Liu Q; Liu M; Shi P; Zhu L; Zhang L; Li R
    J Biomater Appl; 2019 May; 33(10):1382-1393. PubMed ID: 30880565
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Hyaluronic acid oligosaccharide modified redox-responsive mesoporous silica nanoparticles for targeted drug delivery.
    Zhao Q; Geng H; Wang Y; Gao Y; Huang J; Wang Y; Zhang J; Wang S
    ACS Appl Mater Interfaces; 2014 Nov; 6(22):20290-9. PubMed ID: 25311422
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Simple preparation of maltose-functionalized dendrimer/graphene quantum dots as a pH-sensitive biocompatible carrier for targeted delivery of doxorubicin.
    Karimi S; Namazi H
    Int J Biol Macromol; 2020 Aug; 156():648-659. PubMed ID: 32289413
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Embedding fluorescent mesoporous silica nanoparticles into biocompatible nanogels for tumor cell imaging and thermo/pH-sensitive in vitro drug release.
    Gui R; Wang Y; Sun J
    Colloids Surf B Biointerfaces; 2014 Apr; 116():518-25. PubMed ID: 24576821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.